Why is Eiko Lifescience falling/rising?

As of 15-Jul, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 54.00, which reflects a decrease of Rs 2.64 or 4.66%. The stock has underperformed its sector today by 5.47%, reaching an intraday low of Rs 53.15, which is a drop of 6.16%. Over the past week, the stock has seen a significant decline of 10.58%, while its performance over the last month shows a modest increase of 6.53%. However, the stock has underperformed the benchmark indices over the longer term, with a year-to-date return of -13.93% compared to a 5.67% gain in the Sensex. Despite a recent increase in promoter confidence, with a 4.96% rise in their stake, the company's weak long-term fundamentals, including a low return on equity (ROE) of 2.82% and a significant drop in net sales, contribute to the stock's downward trend.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as it has underperformed the Sensex by a considerable margin in both the short and long term. While the Sensex has gained 1.79% over the past month, Eiko Lifesciences has managed only a 6.53% increase, which is overshadowed by its substantial declines over the past year and three years. The falling investor participation, indicated by a 69.25% drop in delivery volume, further suggests a lack of confidence among investors, reinforcing the stock's negative trajectory amidst a generally stable market environment.